Sanofi Creates Ophtho Division through Earn-Out Acquisition of Fovea
This article was originally published in The Pink Sheet Daily
By buying its Paris-based neighbor, Sanofi-Aventis creates an ophthalmology division and a chance to license more.
You may also be interested in...
The Paris-based start-up has raised €32 million from venture investors to address two orphan eye disorders, taking advantage of new research and manufacturing techniques in gene therapy.
France's NicOx, aiming to transform into a specialty ophthalmology company after several late-stage disappointments, announced plans to acquire VC-backed U.K startup Altacor.
Belgian start-up raises record-breaking €18 million A round to take rho kinase inhibitor glaucoma candidate to clinical proof-of-concept.